Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.
J Nucl Med. 2022 Nov;63(11):1642-1643. doi: 10.2967/jnumed.122.264299. Epub 2022 Jul 7.
J Nucl Med. 2022.
PMID: 35798555
No abstract available.